Max Tejada is a scientific leader with expertise in clinical development and GMP, currently serving as the Head of Analytical Development and Quality Control at Genentech. They have previously held significant roles at Kite Pharma, AstraZeneca, and Sana Biotechnology, where they guided successful projects in gene edited cellular therapies and led teams across various scientific disciplines. Holding a PhD from Queen's University and an ongoing MBA from Notre Dame de Namur University, Max has a proven track record of achieving regulatory approvals for cancer therapies while mentoring the next generation of scientists.
This person is not in the org chart
This person is not in any teams
This person is not in any offices